Shimizu Makiko, Murayama Norie, Nagashima Satomi, Fujieda Masaki, Yamazaki Hiroshi
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo, Japan.
Drug Metab Pharmacokinet. 2008;23(1):54-8. doi: 10.2133/dmpk.23.54.
We reported the human flavin-containing monooxygenase 3 (FMO3) haplotypes (Pharmacogenet. Genomics: 17, 827, 2007). The objective was to gain the insight into transcriptional regulation in a Japanese population. The wild-type FMO3 reporter plasmids carrying 5'-flanking sequence from the transcriptional initiation site of the FMO3 haplotype 1 (prepared from three individuals) showed higher luciferase activities in HepG2 cells than those from the FMO3 haplotypes 2 and 3, with the wild-type coding region. Several deletion mutants of the FMO3 haplotype 1 (extending from -5,167 to -1,764, numbered relative to the A of the ATG translational initiation codon) revealed that the region of -2,064 to -1,804 contained an important cis-acting element(s) for activation of the FMO3 gene expression. Putative hepatocyte nuclear factor-4 (HNF-4) binding site and CCAAT box, but not Yin Yang 1 element, could be responsible cis-acting elements of the FMO3 gene, by site-directed mutagenesis analysis. The unknown suppressive cis-element(s) at the 5'-upstream region from -2,064 might show genetic polymorphism, because the FMO3 haplotypes 2 and 3 had three and ten mutations, respectively. These results suggest that the putative HNF-4 binding site and CCAAT box could be responsible cis-acting elements of the FMO3 gene in Japanese.
我们报道了人类含黄素单加氧酶3(FMO3)单倍型(《药物遗传学与基因组学》:17,827,2007)。目的是深入了解日本人群中的转录调控。携带FMO3单倍型1转录起始位点5'侧翼序列的野生型FMO3报告质粒(由三名个体制备)在HepG2细胞中显示出比携带野生型编码区的FMO3单倍型2和3更高的荧光素酶活性。FMO3单倍型1的几个缺失突变体(从-5,167延伸至-1,764,相对于ATG翻译起始密码子的A进行编号)表明,-2,064至-1,804区域包含激活FMO3基因表达的重要顺式作用元件。通过定点诱变分析,推定的肝细胞核因子-4(HNF-4)结合位点和CCAAT框而非阴阳1元件可能是FMO3基因的顺式作用元件。-2,064上游5'区域未知的抑制性顺式元件可能存在基因多态性,因为FMO3单倍型2和3分别有三个和十个突变。这些结果表明,推定的HNF-4结合位点和CCAAT框可能是日本人FMO3基因的顺式作用元件。